Core Biogenesis
Entrepreneur First '20Paris, FR · Founded 2020 · 3 known investors
Core Biogenesis is a French biotech that uses an oleosome fusion platform to grow active peptides and proteins (such as EGF and FGF-2) inside camelina seeds, producing formulation-ready topical delivery carriers for skin and scalp. It supplies these recombinant protein actives to the cosmetics and personal care industry, serving formulators, R&D teams, and brands.
Founders & leadership
Core Biogenesis was founded in 2020 by Alexandre Reeber and Chouaib Meziadi.
AR
Alexandre ReeberinCo-founderAlexandre trained in biotechnology and neuroscience, holding a bachelor's in Biomedical Science from the Université de Strasbourg and a master's in Neuroscience from Albert-Ludwigs-Universität Freiburg. He has also worked as a project manager in the neurotechnology sector.
CM
Chouaib MeziadiinCo-founderChouaib received his PhD in Plant Genetics from Université Paris-Saclay and went on to a postdoctoral position in plant epigenetics. He is an author on ten peer-reviewed publications.
Investors · 3
Frequently asked questions
- What does Core Biogenesis do?
- Core Biogenesis is a French biotech that uses an oleosome fusion platform to grow active peptides and proteins (such as EGF and FGF-2) inside camelina seeds, producing formulation-ready topical delivery carriers for skin and scalp. It supplies these recombinant protein actives to the cosmetics and personal care industry, serving formulators, R&D teams, and brands.
- Who founded Core Biogenesis?
- Core Biogenesis was founded by Alexandre Reeber, Chouaib Meziadi in 2020.
- Who are Core Biogenesis's investors?
- Core Biogenesis's investors include Blue Horizon Corporation, Entrepreneur First, XAnge.
- Where is Core Biogenesis headquartered?
- Core Biogenesis is headquartered in Paris, FR.